Zepp Health Q4 2025 slides: 43% revenue surge, record margins By Investing.com

Zepp Health reported Q4 revenue of $85.2M, up 43% YoY, with record Q4 gross margin of 40.4% (up 360 bps YoY) and Q4 adjusted net loss narrowing 71.6% to $6.4M. FY2025 revenue was $258.9M with an adjusted net loss attributable to Zepp of $31.5M (improved 44.4% YoY); R&D and G&A each fell to $42M and the company repurchased $16.2M of shares. Guidance for Q1 2026 is $50–$55M (≈+30–43% YoY), indicating continued momentum; shares rose ~1.17% aftermarket to $20.59 but remain far below the 52-week high of $61.85.

Analysis

The structural pivot to premium branded wearables creates a higher-ASP, higher-margin business model whose next moves will be decided more by brand economics and services monetization than by unit volume. That shifts the competitive battleground away from low-cost OEM supply chains toward display/sensor suppliers, premium casing and software/OS incumbents — a change that amplifies margins but concentrates execution risk in marketing, channel expansion, and software retention.

Key catalysts are cadence and durability: near-term guidance or commentary can move the stock on perception of international traction, while multi-quarter metrics — recurring services ARPU, attach rate for premium bands/cases, and gross margin stabilization — are the true determiners of sustainable value. Main reversal vectors are easy: if competitors compress pricing in key markets or if channel inventory builds, elevated margins can evaporate quickly; likewise, component cost inflation or platform issues (OS/firmware churn) would force either margin sacrifice or slower growth.

Second-order effects create concrete long/short opportunities. Suppliers of high-end panels, biometric sensors, and small-batch premium manufacturing stand to see order mix improvements, while legacy OEM contract revenue pools will reallocate to fewer players and smaller margins. Finally, management buybacks reduce float and can amplify rallies, but also leave less dry powder to withstand a prolonged promotional cycle — watch incremental buyback cadence versus investment in international marketing as the decisive signal of priorities.

Key Decisions for Investors

• Long ZEPP (ZEPP) equity — build a core position on a pullback of ~10% or on a softening headline that doesn’t alter margin trajectory; horizon 9–12 months, target +80–120% if branded premiumization and services ARPU scale, stop -35% to control execution risk.
• Paired trade: long ZEPP / short Garmin (GRMN) — equal-dollar exposure to isolate premium wearables share gains versus legacy GPS/sports specialist over 9–12 months; target relative outperformance of 40–60%, hard stop if ZEPP lags while GRMN posts accelerating ASPs or if macro squeezes both equally.
• Options: buy 12‑month ZEPP LEAPS (deep enough OTM to reflect conviction) financed by selling 1–3 month calls in a 1:2 ratio — objective to capture multi-quarter margin improvement while reducing cost basis; monitor implied vol for rolling adjustments, unwind if next two quarterly margins decline sequentially.
• Tactical long on select suppliers (SMCI) — 3–6 month trade to capture backend/server/infra demand from growing device-service ecosystems and potential increases in telemetry/back‑end processing; target +30–50%, stop -20% on signs of enterprise capex pullback.